CAS No |
Product Name |
Molecular Formula |
208647-48-7
|
1-Naphthyl alpha-D-glucopyranoside
|
C16H18O6
|
208651-58-5
|
Phosphoric acid mono(4-nitrophenyl) ester monopotassium salt
|
C6H6NO6P.K
|
208663-08-5
|
(2E)-4-[(5-Chloro-2-Methylphenyl)Amino]-4-Oxo-2-Butenoic Acid
|
C11H10ClNO3
|
208665-95-6
|
3-Bromo-4-isobutoxybenzonitrile;3-Bromo-4-(2-methylpropoxy)benzonitrile
|
C11H12BrNO
|
208709-55-1
|
1-Butoxy-2,3-difluoro-4-(trans-4-propylcyclohexyl)benzene;3-HB(2F,2F)-O4; 3-HB(2F,3F)-O4; PCH 304FF
|
C19H28F2O
|
208720-71-2
|
Oseltamivir EP Impurity E;Oseltamivir Acid Methyl Ester;methyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate
|
C15H26N2O4
|
208772-23-0
|
4-Benzoxazolecarboxylic acid
|
C8H5NO3
|
208772-41-2
|
1-{[(2-Methyl-2-Propanyl)Oxy]Carbonyl}-6-Indolinecarboxylic Acid
|
C14H17NO4
|
208774-11-2
|
1-{[(2-Methyl-2-Propanyl)Oxy]Carbonyl}-4-Indolinecarboxylic Acid
|
C14H17NO4
|
208774-29-2
|
1,4-Dihydro-4-oxo-5-quinazolinecarboxylic acid
|
C9H6N2O3
|
208777-19-9
|
1-(2-Fluoro-3-Methoxyphenyl)Ethanone
|
C9H9FO2
|
208848-19-5
|
Freselestat;5-Amino-N-(1-((5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2-yl)carbonyl)-2-methylpropyl)-6-oxo-2-phenyl-1(6H)-pyrimidineacetamide; ONO 6818; ONO-PO 736
|
C23H28N6O4
|
208938-48-1
|
4-(1,3-Benzothiazol-2-Yl)-1,2-Oxazol-5-Amine
|
C10H7N3OS
|
208944-55-2
|
Methyl 3-Amino-5-(4-Isobutylphenyl)-2-Thiophenecarboxylate
|
C16H19NO2S
|
208987-48-8
|
1-Butyl-3-(1-naphthoyl)indole;(1-Butyl-1H-indol-3-yl)-1-naphthalenylmethanone
|
C23H21NO
|
209052-80-2
|
Methyl 4-(4-Chlorophenoxy)Butyrate
|
C11H13ClO3
|
209115-32-2
|
9H-Fluoren-9-Ylmethyl (4-Hydroxybutyl)Carbamate
|
C19H21NO3
|
209128-50-7
|
(1R,2R)-2-({[(2-Methyl-2-Propanyl)Oxy]Carbonyl}Amino)Cyclohexanecarboxylic Acid
|
C12H21NO4
|
209161-73-9
|
Acetoxymethyl ([2-(Acetoxymethoxy)-2-Oxoethyl]{2-[2-(2-{Bis[2-(Acetoxymethoxy)-2-Oxoethyl]Amino}-5-[Hydroxy(6-Nitro-1,3-Benzodioxol-5-Yl)Methyl]Phenoxy)Ethoxy]-4-Methylphenyl}Amino)Acetate
|
C43H47N3O23
|
209163-25-7
|
3-(((9H-Fluoren-9-ylmethoxy)carbonyl)amino)-2-oxo-1-piperidineacetic acid;Fmoc-(R,S)-3-1-carboxymethyl-2-valerolactame
|
C22H22N2O5
|
209216-23-9
|
Entecavir hydrate;2-Amino-1,9-dihydro-9-((1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-6H-purin-6-one monohydrate
|
C12H15N5O3.H2O
|
209223-32-5
|
N-((1,1-Dimethylethoxy)carbonyl)-3-((2-nitrophenyl)amino)-D-alanine
|
C14H19N3O6
|
209224-89-5
|
5-(1-Naphthyl)-1H-Pyrazol-3-Amine
|
C13H11N3
|
209224-90-8
|
5-(2-Naphthyl)-1H-Pyrazol-3-Amine
|
C13H11N3
|
209224-91-9
|
5-[3-(Trifluoromethyl)Phenyl]-1H-Pyrazol-3-Amine
|
C10H8F3N3
|
209252-15-3
|
Fmoc-(S)-3-Amino-3-phenylpropionic acid;(S)-N-Fmoc-3-Amino-3-phenylpropionic acid
|
C24H21NO4
|
209252-16-4
|
Fmoc-D-beta-homophenylalanine;(R)-3-(9H-Fluoren-9-ylmethoxycarbonylamino)-4-phenylbutyric acid
|
C25H23NO4
|
209252-17-5
|
Fmoc-L-beta-glutamic acid 5-tert-butyl ester;Fmoc-L-beta-homoaspartic acid 5-tert-butyl ester; Fmoc-beta-Glu(OtBu)-OH
|
C24H27NO6
|
209256-40-6
|
2,3-Dihydrobenzofuran-4-carboxylic acid
|
C9H8O3
|
209256-42-8
|
2,3-Dihydro-4-benzofurancarboxaldehyde
|
C9H8O2
|
209262-62-4
|
2-Bromo-N,N-Dimethylisonicotinamide
|
C8H9BrN2O
|
209262-63-5
|
2-Chloro-N,N-Dimethylisonicotinamide
|
C8H9ClN2O
|
209266-79-5
|
Potassium (2R)-3-[(4S,6R,7R,10S)-4-[(E,1R)-3-[(2S,2'R,4R,4aS,6R,8aR)-4-Hydroxy-2-[(1S,3S)-1-Hydroxy-3-[(6S,9R,10S)-9-Methyl-5,11-Dioxaspiro[5.5]Undecan-10-Yl]Butyl]-3-Methylene-Spiro[4A,7,8,8A-Tetrahydro-4H-Pyrano[3,2-b]Pyran-6,5'-Tetrahydrofuran]-2'-Yl]-1-Methyl-Allyl]-7-Hydroxy-2-Methyl-5,11-Dioxaspiro[5.5]Undec-1-En-10-Yl]-2-Hydroxy-2-Methyl-Propanoate
|
C44H67KO13
|
209266-80-8
|
Okadaic acid sodium salt
|
C44H67O13.Na
|
209285-92-7
|
7-(Bromomethyl)-1-Chloroisoquinoline
|
C10H7BrClN
|
209286-63-5
|
2-(Bromomethyl)-4-chlorothieno(3,2-c)pyridine
|
C8H5BrClNS
|
209286-73-7
|
1-Chloro-6-methylisoquinoline
|
C10H8ClN
|
209286-97-5
|
2-Iodopyridin-3-ylamine
|
C5H5IN2
|
209325-69-9
|
N-(Phenylmethyl)-L-isoleucine methyl ester
|
C14H21NO2
|
209328-55-2
|
3-Fluoro-5-hydroxypyridine
|
C5H4FNO
|
209328-72-3
|
3-Chloro-2-fluoro-5-hydroxypyridine
|
C5H3ClFNO
|
209328-85-8
|
2,6-Difluoro-3-Pyridinol
|
C5H3F2NO
|
209328-87-0
|
2-Fluoro-6-Methyl-3-Pyridinol
|
C6H6FNO
|
209328-99-4
|
2-Fluoro-3-bromo-5-aminopyridine;5-Amino-3-bromo-2-fluoropyridine
|
C5H4BrFN2
|
209329-11-3
|
2-Azetidinylmethanol
|
C4H9NO
|
209342-40-5
|
Finafloxacin;8-Cyano-1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydropyrrolo(3,4-b)-1,4-oxazin-6(2H)-yl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid; Xtoro
|
C20H19FN4O4
|
209342-41-6
|
Finafloxacin hydrochloride;8-Cyano-1-cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydropyrrolo(3,4-b)-1,4-oxazin-6(2H)-yl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid monohydrochloride
|
C20H19FN4O4.HCl
|
209347-66-0
|
3-(3,7-Dimethyloctyloxy)benzeneboronic acid
|
C16H27BO3
|
209347-80-8
|
1-[(3,7-Dimethyloctyl)Oxy]-4-Methoxybenzene
|
C17H28O2
|
209347-94-4
|
5-Bromo-6-chloro-1H-indol-3-yl octanoate;Octanoic acid 5-bromo-6-chloro-1H-indol-3-yl ester; Magenta C 8
|
C16H19BrClNO2
|